Abstract:Evidence from large epidemiological studies has shown that obesity may predispose to increased Th2 inflammation and increase the odds of developing asthma. On the other hand, there is growing evidence suggesting that metabolic dysregulation that occurs with obesity, and more specifically hyperglycemia and insulin resistance, may modify immune cell function and in some degree systemic inflammation. Insulin resistance seldom occurs on its own, and in most cases constitutes a clinical component of metabolic syndrome, along with central obesity and dyslipidemia. Despite that, in some cases, hyperinsulinemia associated with insulin resistance has proven to be a stronger risk factor than body mass in developing asthma. This finding has been supported by recent experimental studies showing that insulin resistance may contribute to airway remodeling, promotion of airway smooth muscle (ASM) contractility and proliferation, increase of airway hyper-responsiveness and release of pro-inflammatory mediators from adipose tissue. All these effects indicate the potential impact of hyperinsulinemia on airway structure and function, suggesting the presence of a specific asthma phenotype with insulin resistance. Epidemiologic studies have found that individuals with severe and uncontrolled asthma have a higher prevalence of glycemic dysfunction, whereas longitudinal studies have linked glycemic dysfunction to an increased risk of asthma exacerbations. Since the components of metabolic syndrome interact with one another so much, it is challenging to identify each one's specific role in asthma. This is why, over the last decade, additional studies have been conducted to determine whether treatment of type 2 diabetes mellitus affects comorbid asthma as shown by the incidence of asthma, asthma control and asthma-related exacerbations. The purpose of this review is to present the mechanism of action, and existing preclinical and clinical data, regarding the effect of insulin resistance in asthma.

Obesity and Insulin Resistance in Asthma Pathogenesis and Clinical Outcomes

Unraveling the Link between Ιnsulin Resistance and Bronchial Asthma

Obesity-related Asthma: A Pathobiology-based Overview of Existing and Emerging Treatment Approaches.

Obesity and Hormonal Influences on Asthma: Mechanisms, Management Challenges, and Emerging Therapeutic Strategies

Obesity-related asthma: new insights leading to a different approach

Asthma and Obesity: Two Diseases on the Rise and Bridged by Inflammation

Obesity, Inflammation, and Severe Asthma: an Update

Association of Obesity and Severe Asthma in Adults

PATHOGENETIC ASPECTS OF THE PHENOTYPE OF BRONCHIAL ASTHMA ASSOCIATED WITH OBESITY

Obesity alters inflammatory response in the pathology of asthma (Review)

Impact of obesity on airway remodeling in asthma: pathophysiological insights and clinical implications

A clinician's guide to effects of obesity on childhood asthma and into adulthood

Targeting Lipid Metabolism in Obese Asthma: Perspectives and Therapeutic Opportunities

Effects of biological therapies on patients with Type-2 high asthma and comorbid obesity

Weight Loss Interventions for Adults With Obesity-Related Asthma

Obesity and Selected Allergic and Immunological Diseases—Etiopathogenesis, Course and Management

Asthma and Hyperglycemia: Exploring the Interconnected Pathways

The Role of Peptides in Asthma–Obesity Phenotype

Body Weight and Allergic Asthma: A Narrative Review

Asthma, obesity and targeted interventions: an update

Pathophysiological relation between the systemic inflammation and the state of small airways in mild asthma with obesity